NeOnc Technologies to discuss Phase 2a glioma trial results Aug. 12
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) announced it will host an investor conference call on August 12, 2026, at 5:30 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
